1023742-13-3 Usage
Uses
Used in Organic Synthesis:
O-(2-tert-butoxyethyl)hydroxylaMine is used as a reagent in organic synthesis for its ability to facilitate the preparation of pharmaceuticals and agrochemicals. Its unique structure allows for specific reactions that are crucial in the synthesis of these compounds.
Used in Pharmaceutical Industry:
In the Pharmaceutical Industry, O-(2-tert-butoxyethyl)hydroxylaMine is used as an intermediate in the production of various drugs. Its role in the synthesis process is vital for creating the desired medicinal compounds.
Used in Agrochemical Industry:
Similarly, in the Agrochemical Industry, O-(2-tert-butoxyethyl)hydroxylaMine is utilized as an intermediate for the synthesis of agrochemicals, contributing to the development of products used in agriculture.
Used in Chemical Production:
O-(2-tert-butoxyethyl)hydroxylaMine is also used as an intermediate in the production of other chemicals such as rubber antioxidants and corrosion inhibitors, highlighting its broad application across different chemical sectors.
Safety Note:
It is important to handle O-(2-tert-butoxyethyl)hydroxylaMine with care due to its potential to cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken to minimize exposure and ensure safe usage.
Check Digit Verification of cas no
The CAS Registry Mumber 1023742-13-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,3,7,4 and 2 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1023742-13:
(9*1)+(8*0)+(7*2)+(6*3)+(5*7)+(4*4)+(3*2)+(2*1)+(1*3)=103
103 % 10 = 3
So 1023742-13-3 is a valid CAS Registry Number.
1023742-13-3Relevant articles and documents
Method for synthesizing azanol
-
Paragraph 0156-0158, (2016/10/08)
The invention relates to a hydroxylamine synthesis method. The hydroxylamine synthesis method comprises the following steps: (A) enabling alcohol to react with alkyl sulfonyl halide in the presence of an acid-binding agent to obtain sulphonate; (B) enabling the obtained sulphonate in the step (A) to react with N-hydroxycyclodiimide in the presence of alkali to generate alkylate of the N-hydroxycyclodiimide; and (C) enabling the alkylate obtained in the step (B) to react with an aminolysis reagent or a hydrazinolysis reagent to obtain the hydroxylamine. The method is high in yield and suitable for large-scale industrial hydroxylamine synthesis.
KINASE INHIBITORS AS THERAPEUTIC AGENTS
-
Page/Page column 293, (2010/02/14)
A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.